Patients can hardly benefit from the government's drug price reduction policies: analysis of hospitals'cephalosporin using during top 100 medical prescription drugs from 2000 to 2008 in Shanghai Take cephalosporin drugs as an example
Kui-ying YE,Ying WANG,Dao-li ZHU,Shan-jian TANG,Qi-wu JIANG,Wei-dong QU,Zhi-jun ZHOU,Wei DONG,Yan-bing ZENG,Zhao-xin WANG,Lian-zeng GUO,Xiao-hong LI,Cheng-yue Li,Song-guang LI,Xin CUI,Mei SUN,Feng-shui CHANG,Li LUO,Jun LV,Mo HAO
DOI: https://doi.org/10.3969/j.issn.1007-953X.2010.04.002
2010-01-01
Abstract:Objectives:To analyze hospitals' cephalosporin using in the top 100 medical prescription drugs from 2000 to 2008 in Shanghai and specify the impact of drug price reduction policies on hospital's cephalosporin buying and using.Methods:Analyze the sales amount,weighted price,dosage forms,and specification of cephalosporin of the top 100 medicines that hospitals purchased during 2000-2008 in Shanghai.Results and discussion: Drug price reduction policies can not reduce the cost burden of drugs,Only through the implementation of payment reforms, the introduction of total pay in advance,stimulate the hospital to save costs actively and cut off the association between health care institutions and drug revenues effectively,can solve the problem of over-high drug prices and restore the normal order of the pharmaceutical market.